Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Conn Med ; 79(2): 69-76, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26244203

RESUMEN

BACKGROUND: Racial and ethnic disparities in hospital readmissions for several major illnesses and conditions are well-documented. However, due to the data typically used to assess readmission disparities little is known regarding the interplay between race/ethnicity and payer in fostering readmissions. This study used a statewide database of acute-care hospital admissions to examine 30-day readmission rates following hospitalization for chest pain and heart failure byrace/ethnicity and insurance status. METHODS: Connecticut hospital discharge data for patients admitted for Chest Pain-DRG 313 (n = 23,450) and Heart Failure and Shock-DRG 291 and 292 (n = 39,985) from 2008 - 2012 were analyzed using marginal logistic models for clustered data with generalized estimating equations. RESULTS: Results from logistic models indicated that Black patients were significantly more likely to be readmitted within 30 days of discharge following hospitalization for chest pain (OR = 1.19, CI = 1.04, 1.37) than were White patients. Hispanics, but not Blacks, were significantly more likely to be readmitted within 30 days of discharge following hospitalization for heart failure (OR = 1.30, CI = 1.15, 1.47). Rates of 30-day readmission across these conditions were between 50-100% higher among those covered by Medicaid compared to those covered by private payer. Controlling for patient socioeconomic status, patient comorbidities, and payer substantially reduced Black/White differences in the odds of readmission for chest pain but did not reduce Hispanic-White differences for heart failure. CONCLUSIONS: Racial and ethnic disparities were seen in hospital readmission rates for Chest Pain (DRG 313) and Heart Failure and Shock (DRG 291 and 292) when a statewide database that captures all acute care hospital admissions was analyzed. When controlling for patient socioeconomic status, comorbidities, and payer status, the difference in the odds of readmission for chest pain, but not heart failure, was reduced.


Asunto(s)
Dolor en el Pecho/etnología , Disparidades en Atención de Salud , Insuficiencia Cardíaca/etnología , Readmisión del Paciente/estadística & datos numéricos , Anciano , Connecticut , Etnicidad/estadística & datos numéricos , Femenino , Humanos , Seguro de Salud , Masculino , Medicaid , Medicare , Persona de Mediana Edad , Estados Unidos
3.
J Clin Gastroenterol ; 43(4): 338-41, 2009 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19077729

RESUMEN

INTRODUCTION: Isolated angioedema of the small intestine is a rare entity. The cases described have been related with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, or C1 esterase inhibitor deficiency. We present a case of small intestine angioedema caused by calcium channel blockers (CCBs) and a review of the literature. CASE REPORT: Over the course of approximately 2 years, a 56-year-old African American woman presented to our hospital with 8 similar episodes of diffuse, intermittent abdominal pain, nausea, vomiting, and diarrhea. The diagnostic workup was extensive and included normal stool studies, anticardiolipin antibodies, antinuclear antibodies, antineutrophil cytoplasmic antibodies, cryoglobulin studies, complement levels, urinary 5-hydroxyindoleacetic acid, and serum markers for inflammatory bowel diseases. A computed tomographic angiogram was normal. Abdominal computed tomographic scans showed prominent mural thickening of different intestinal segments, always involving the ileum. An esophagogastroduodenoscopy showed patchy edematous, violaceous folds in the second portion of the duodenum. Colonoscopy revealed a markedly edematous and erythematous distal ileum. The recurrences subsided after CCBs were discontinued in this patient and reoccurred when they were incidentally restarted. CONCLUSIONS: Our case demonstrates that CCBs can cause isolated intestinal angioedema with distinctive endoscopic findings. The discontinuation of the involved medication is the key for both diagnosis and treatment.


Asunto(s)
Amlodipino/efectos adversos , Angioedema/inducido químicamente , Bloqueadores de los Canales de Calcio/efectos adversos , Intestino Delgado , Dolor Abdominal/diagnóstico , Dolor Abdominal/diagnóstico por imagen , Dolor Abdominal/tratamiento farmacológico , Angioedema/diagnóstico por imagen , Diarrea/diagnóstico , Diarrea/diagnóstico por imagen , Diarrea/tratamiento farmacológico , Femenino , Humanos , Enfermedades Intestinales/inducido químicamente , Enfermedades Intestinales/diagnóstico por imagen , Intestino Delgado/diagnóstico por imagen , Intestino Delgado/patología , Persona de Mediana Edad , Radiografía
4.
ACG Case Rep J ; 1(1): 29-32, 2013 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26157814

RESUMEN

Intestinal malrotation is an anomaly of fetal intestinal rotation that can present with symptoms after birth or in early childhood, but is rarely diagnosed in adults. Patients who have symptomatic presentations require surgery. Other entities may mimic intestinal malrotation and respond to non-surgical management. We present 2 adult cases with the radiological diagnosis of intestinal malrotation: one with true malrotation presenting as a duodenal mass, and another with "pseudo-malrotation" due to altered anatomy. These cases illustrate the importance of recognizing and differentiating these rare adult presentations of true malrotation from "pseudo-malrotation" in regards to their acute management.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA